There is likely to be significant methodological heterogeneity in clinical trials of non-pharmacological interventions for postviral syndromes, which may limit our ability to pool treatment effects.
← all excerpts
Non-pharmacological therapies for postviral syndromes, including Long COVID: a systematic review and meta-analysis protocol.
1
—
—